Measles does not cause infertility in most people, but it can in a small, specific subgroup: unvaccinated males who develop orchitis as a complication. Measles orchitis occurs in roughly 1 in 1,000 to 1 in 20,000 male cases, and testicular inflammation can damage sperm-producing tissue. Infertility from measles is rare, not impossible. By contrast, mumps is far more likely to affect fertility. The larger, better-documented threat from measles is pregnancy loss and premature birth in uninfected pregnant women who catch it.
Measles is one of the most contagious viruses known. A single infected person can spread it to 12 to 18 susceptible people in a fully unexposed population, a figure virologists call the basic reproduction number. That transmissibility explains why measles outbreaks still surface in 2026 in communities with vaccination gaps, even in wealthy countries. To understand infertility risk, you have to follow the virus into specific organs, and separate what data show from what one disease is often blamed for.
The misconception: measles and mumps get confused
Most online worry about measles and infertility traces back to mumps, not measles. Mumps is the classic cause of viral orchitis. Before widespread vaccination, mumps orchitis struck 20 to 30 percent of post-pubertal male cases. Measles orchitis is dramatically rarer, reported at roughly 0.05 to 0.1 percent of male cases in outbreak reviews. In plain terms: the disease most people are actually thinking of when they fear measles-related infertility is mumps.
That confusion matters because it distorts risk perception and vaccination decisions. Mumps orchitis can cause testicular atrophy in about one-third of affected men and impaired sperm counts in a subset. Measles can do something similar but far less often. The two viruses belong to different families — measles is a paramyxovirus, mumps is also a paramyxovirus, but their tropism and complication profiles differ. Lumping them together inflates the measles risk estimate by roughly 100 to 300 fold.
How measles could affect fertility: the mechanisms
The mechanism runs through orchitis, meaning inflammation of the testes. Measles virus reaches the testis through the bloodstream during the viremic phase, typically 5 to 7 days after exposure and around 2 to 5 days before the rash appears. The virus infects testicular endothelial cells and triggers an immune response that causes swelling, pain, and localized heat. The fever that accompanies measles, often 103 to 105 degrees Fahrenheit, adds a separate stressor.
Testicular damage in orchitis comes from two sources. First, the inflammatory response compresses the seminiferous tubules where sperm mature. Second, the elevated scrotal temperature, sometimes sustained for 3 to 7 days, temporarily impairs spermatogenesis. Sustained damage requires severe inflammation. In most reported measles orchitis cases, symptoms resolve within 1 to 3 weeks, and fertility recovers. Permanent impairment is the exception, tied to severe bilateral orchitis or testicular atrophy documented on follow-up.
There is also an indirect pathway in females, but it is not direct viral damage to the ovaries. Measles during pregnancy raises the risk of miscarriage and preterm delivery, which are pregnancy outcomes rather than fertility loss. Measles does not appear to attack ovarian tissue the way it can attack testicular tissue. The asymmetry is one of the more notable, and underreported, features of the disease.
Quantified risk: how rare measles orchitis really is
The numbers matter because they separate alertness from alarm. Measles orchitis is rare enough that many clinicians never see a case in a career. Large outbreak analyses, including reviews of adult male measles cases, place orchitis at the low end of viral complications, far below the rates seen with mumps.
| Complication | Affected group | Approximate rate | Typical fertility impact |
|---|---|---|---|
| Mumps orchitis | Post-pubertal males | 20 to 30 percent of cases | Testicular atrophy in about 33 percent of those affected |
| Measles orchitis | Adult males | 0.05 to 0.1 percent of cases | Usually transient; permanent impairment rare |
| Measles pneumonia | All ages | 1 in 20 cases | No direct fertility effect |
| Measles encephalitis | All ages | 1 in 1,000 cases | No direct fertility effect |
| Measles in pregnancy | Pregnant women | Miscarriage and preterm risk elevated | Pregnancy loss, not sterility |
The comparison is stark. Mumps orchitis is roughly 200 to 600 times more common than measles orchitis in male cases. Even among men who develop measles orchitis, the majority recover testicular function. A 2020 review of adult measles complications found permanent testicular atrophy reported only in isolated case reports, not in systematic follow-up. This is the difference between a real risk and a headline risk.
Timeline: from infection to fertility outcomes
The course of measles and any reproductive consequence follows a predictable arc. The table below traces typical timing in an adult male who develops orchitis. Timing varies by individual, and most men never enter the orchitis rows at all.
| Day | Stage | What happens |
|---|---|---|
| Day 0 | Exposure | Virus enters via respiratory tract |
| Day 7 to 10 | Viremia | Virus spreads through blood; fever begins |
| Day 10 to 12 | Orchitis onset (rare cases) | Testicular swelling and pain appear |
| Day 12 to 14 | Rash | Characteristic measles rash appears |
| Day 14 to 21 | Orchitis resolution | Swelling subsides in most cases |
| Week 3 to 4 | Recovery | Fever resolves; sperm parameters begin normalizing |
| Month 2 to 3 | Fertility reassessment | Semen analysis, if done, typically returns to baseline |
The key point for anyone worried about fertility is timing. Spermatogenesis takes about 74 days per cycle, so a temporary insult during orchitis does not permanently damage all sperm. The body replaces sperm continuously. Permanent impairment requires destruction of the spermatogonial stem cells themselves, which severe orchitis can do but usually does not.
Who is actually at risk
The risk is concentrated, not spread evenly. Men who are unvaccinated and develop measles as adults face the orchitis risk. The rate of orchitis in prepubertal boys is negligible because the testes are not yet actively producing sperm. This is why the complication profile shifts with age and why adult measles is taken more seriously in men.
Unvaccinated pregnant women face a different, larger risk profile. Measles in pregnancy is associated with miscarriage in roughly 20 to 30 percent of cases in some outbreak reports, and preterm birth in a similar range. These are not infertility outcomes in the strict sense, but they are reproductive losses. The distinction matters for counseling. A woman who has measles and miscarries has not lost her fertility, but she has suffered a pregnancy complication that deserves care.
People with weakened immune systems, including those on chemotherapy or with HIV, face higher complication rates across the board. For them, measles orchitis risk, while still low, is not zero, and fertility preservation discussions may be relevant if they are also receiving gonadotoxic treatment.
What to actually do
The fertility conversation around measles is mostly a vaccination conversation. Two doses of the MMR vaccine, which protects against measles, mumps, and rubella, provide about 97 percent protection against measles. The same vaccine protects against mumps, which is the larger fertility threat. Vaccination before puberty, or at least before adulthood, is the single most effective step.
Positive actions, in order of impact:
- Confirm your MMR vaccination status, especially if you were born after 1957 and lack documentation of two doses.
- If unvaccinated and not pregnant, get vaccinated; live vaccines are avoided during pregnancy, so plan ahead.
- Men who develop measles and testicular pain should seek evaluation promptly, as early supportive care reduces inflammation duration.
- Men recovering from orchitis can request a semen analysis 2 to 3 months after recovery to confirm fertility.
- Pregnant women exposed to measles should contact their clinician quickly; immune globulin can be considered within 6 days of exposure.
- Anyone planning pregnancy should verify immunity beforehand, since measles in pregnancy carries the miscarriage and preterm risks.
Red-flag symptoms during a measles infection that warrant urgent care:
- Sudden, severe testicular pain with swelling on one or both sides
- High fever persisting beyond 5 days after rash onset
- Difficulty breathing or chest pain, suggesting pneumonia
- Confusion, seizures, or severe headache, suggesting encephalitis
- In pregnancy, any bleeding or contractions after measles exposure
Limitations of the evidence
What science knows about measles and infertility rests on case reports and outbreak reviews, not large prospective fertility studies. No trial has followed measles orchitis patients for years to measure long-term fertility outcomes, and ethically, none could. That means the low risk figures are best estimates from observed cases, not precise probabilities. Absence of reported infertility in follow-ups is reassuring but not proof of zero risk.
Case reporting also skews toward severe presentations. A man with mild testicular discomfort may never be diagnosed or counted, so the true orchitis rate could be somewhat higher than 0.1 percent, though still far below mumps. Conversely, permanent fertility loss is likely rarer than the case reports suggest, because mild cases that resolve go uncounted. The honest summary is that measles infertility is possible, probably very rare, and concentrated in unvaccinated adult males with severe orchitis.
For most readers, the practical takeaway is that measles is a serious disease for reasons beyond fertility, and vaccination addresses all of them at once. The fertility question is a narrow slice of a much larger risk profile. A reader who confirms immunity has resolved most of the uncertainty the question implies.